Tag
NYSE: ABBV
- Eli Lilly and Company's Omvoh meets pediatric ulcerative colitis remission endpoint
- Zentalis Pharmaceuticals reports 15.8‑month survival in ovarian cancer subgroup
- Edesa Biotech gains FDA clearance to expand Phase 2 vitiligo trial
- Johnson & Johnson raises 2026 outlook after US$25.4B quarterly sales
- AbbVie receives two FDA breakthrough designations for Temab‑A
- Genmab A/S reports 51% lower progression or death risk in Phase 3 lymphoma trial
- Genmab A/S reports 45.9% Rina‑S response in ovarian cancer trial
- DRI Healthcare Trust nears US$316M Juvmo royalty close after FDA approval
- REGENXBIO reports three-year retinopathy improvement in 6 of 10